{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T23:13:27Z","timestamp":1772493207589,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.nano.2022.102598","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T03:35:33Z","timestamp":1662694533000},"page":"102598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["CD24-gold nanocomposite as promising and sensitive biomarker for cancer stem cells in salivary gland tumors"],"prefix":"10.1016","volume":"46","author":[{"given":"Amina Fouad","family":"Farag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia Fathy","family":"Hassabou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2022.102598_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/stemcells.2009.90","article-title":"Stem cell: what's in a name?","author":"Tajbakhsh","year":"2009","journal-title":"Nat Rep Stem Cells"},{"issue":"9","key":"10.1016\/j.nano.2022.102598_bb0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.oraloncology.2011.07.004","article-title":"Advances and applications of oral cancer basic research","volume":"47","author":"da Silva","year":"2011","journal-title":"Oral Oncol"},{"issue":"8","key":"10.1016\/j.nano.2022.102598_bb0015","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.oraloncology.2013.04.012","article-title":"CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics","volume":"49","author":"Noto","year":"2013","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.nano.2022.102598_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-14-173","article-title":"Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma","volume":"14","author":"Han","year":"2014","journal-title":"BMC Cancer"},{"issue":"29","key":"10.1016\/j.nano.2022.102598_bb0025","doi-asserted-by":"crossref","first-page":"26633","DOI":"10.18632\/oncotarget.5782","article-title":"ALDH\/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas","volume":"6","author":"Adams","year":"2015","journal-title":"Oncotarget"},{"issue":"JUN","key":"10.1016\/j.nano.2022.102598_bb0030","first-page":"1","article-title":"Cancer stem cells in oral cavity squamous cell carcinoma: a review","volume":"7","author":"Baillie","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.nano.2022.102598_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/708036","article-title":"Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity","volume":"2012","author":"Jaggupilli","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.nano.2022.102598_bb0040","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.2147\/CMAR.S198348","article-title":"Expression of CD133 and CD24 and their different phenotypes in urinary bladder carcinoma","volume":"11","author":"Farid","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"3","key":"10.1016\/j.nano.2022.102598_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/ntrev-2016-0014","article-title":"Noble metal nanoparticles in biosensors: recent studies and applications","volume":"6","author":"Malekzad","year":"2017","journal-title":"Nanotechnol Rev"},{"issue":"112","key":"10.1016\/j.nano.2022.102598_bb0050","doi-asserted-by":"crossref","first-page":"111482","DOI":"10.1039\/C6RA18760A","article-title":"Engineered gold nanoparticles for photothermal cancer therapy and bacteria killing","volume":"6","author":"Gharatape","year":"2016","journal-title":"RSC Adv"},{"issue":"16","key":"10.1016\/j.nano.2022.102598_bb0055","doi-asserted-by":"crossref","first-page":"19200","DOI":"10.1007\/s11356-019-06459-2","article-title":"Advances in nanomedical applications: diagnostic, therapeutic, immunization, and vaccine production","volume":"27","author":"El-Sayed","year":"2020","journal-title":"Environ Sci Pollut Res Int"},{"issue":"1","key":"10.1016\/j.nano.2022.102598_bb0060","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1166\/jnn.2014.8900","article-title":"Biological applications of gold nanoparticles","volume":"14","author":"Shah","year":"2014","journal-title":"J Nanosci Nanotechnol"},{"key":"10.1016\/j.nano.2022.102598_bb0065","series-title":"Noble and precious metals [Internet]","article-title":"Applications of gold nanoparticles in cancer imaging and treatment","author":"Wang","year":"2018"},{"issue":"18","key":"10.1016\/j.nano.2022.102598_bb0070","article-title":"Progress in research on gold nanoparticles in cancer management","volume":"98","author":"Peng","year":"2019","journal-title":"Med (United States)"},{"issue":"1","key":"10.1016\/j.nano.2022.102598_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12105-011-0281-z","article-title":"Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data","volume":"6","author":"Antony","year":"2012","journal-title":"Head Neck Pathol"},{"issue":"2","key":"10.1016\/j.nano.2022.102598_bb0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2559.2004.01924.x","article-title":"Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy","volume":"45","author":"F\u00e9lix","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.nano.2022.102598_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/250606","article-title":"Immunohistochemical expression of p53 in pleomorphic adenoma and carcinoma ex pleomorphic adenoma","volume":"2010","author":"Tarakji","year":"2010","journal-title":"J Cancer Epidemiol"},{"issue":"7","key":"10.1016\/j.nano.2022.102598_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041261","article-title":"Assessment of TP53 mutations in benign and malignant salivary gland neoplasms","volume":"7","author":"Gomes","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nano.2022.102598_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s11671-015-0856-9","article-title":"Biosynthesis of gold nanoparticles assisted by the intracellular protein extract of Pycnoporus sanguineus and its catalysis in degradation of 4-nitroaniline","volume":"10","author":"Shi","year":"2015","journal-title":"Nanoscale Res Lett"},{"issue":"1","key":"10.1016\/j.nano.2022.102598_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2144\/05391RV01","article-title":"Real-time PCR for mRNA quantitation","volume":"39","author":"Wong","year":"2005","journal-title":"Biotechniques"},{"issue":"3","key":"10.1016\/j.nano.2022.102598_bb0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4103\/0973-029X.151319","article-title":"Epithelial and stromal patterns of pleomorphic adenoma of minor salivary glands: a histopathological and histochemical study","volume":"18","author":"Satpathy","year":"2014","journal-title":"J Oral Maxillofac Pathol"},{"issue":"7","key":"10.1016\/j.nano.2022.102598_bb0110","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00405-010-1437-2","article-title":"Extra-major salivary gland pleomorphic adenoma of the head and neck: a 10-year experience and review of the literature","volume":"268","author":"Kuo","year":"2011","journal-title":"Eur Arch Oto-Rhino-Laryngology"},{"key":"10.1016\/j.nano.2022.102598_bb0115","first-page":"3","article-title":"Pathology and clinical research review article: Open Access","volume":"2","author":"Khalesi","year":"2016","journal-title":"ClinMed"},{"issue":"4","key":"10.1016\/j.nano.2022.102598_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.mpdhp.2020.01.001","article-title":"Salivary gland tumours: diagnostic challenges and an update on the latest WHO classification","volume":"26","author":"Speight","year":"2020","journal-title":"Diagnostic Histopathol"},{"issue":"13","key":"10.1016\/j.nano.2022.102598_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136771","article-title":"2021 update on diagnostic markers and translocation in salivary gland tumors","volume":"22","author":"Meyer","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.nano.2022.102598_bb0130","first-page":"366","article-title":"Salivary gland tumors: a 15-year experience of a univers\u0131ty hospital in Turkey","volume":"7","author":"Mengi","year":"2020","journal-title":"North Clin Istanbul"},{"issue":"3","key":"10.1016\/j.nano.2022.102598_bb0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.coms.2017.03.008","article-title":"Margin analysis: malignant salivary gland neoplasms of the head and neck","volume":"29","author":"Ord","year":"2017","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"4","key":"10.1016\/j.nano.2022.102598_bb0140","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2559.2011.03937.x","article-title":"Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases","volume":"59","author":"Weiler","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.nano.2022.102598_bb0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijsu.2015.04.084","article-title":"Metastasising pleomorphic adenoma: systematic review","volume":"19","author":"Knight","year":"2015","journal-title":"Int J Surg"},{"key":"10.1016\/j.nano.2022.102598_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/148103","article-title":"Metastasizing pleomorphic adenoma: a fascinating enigma","volume":"2012","author":"Santaliz-Ruiz","year":"2012","journal-title":"Case Rep Med"},{"issue":"3","key":"10.1016\/j.nano.2022.102598_bb0155","first-page":"371","article-title":"Stem cells in human breast cancer","volume":"25","author":"Oliveira","year":"2010","journal-title":"Histol Histopathol"},{"issue":"7","key":"10.1016\/j.nano.2022.102598_bb0160","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/his.12109","article-title":"CD24 and CD44 in salivary gland pleomorphic adenoma and in human salivary gland morphogenesis: differential markers of glandular structure or stem cell indicators?","volume":"62","author":"Ianez","year":"2013","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.nano.2022.102598_bb0165","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2559.2005.02058.x","article-title":"Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2\/neu and MIB1 immunohistochemistry","volume":"46","author":"Di Palma","year":"2005","journal-title":"Histopathology"},{"issue":"27","key":"10.1016\/j.nano.2022.102598_bb0170","article-title":"The stem cell marker Bmi-1 is sensitive in identifying early lesions of carcinoma ex pleomorphic adenoma","volume":"94","author":"Sedassari","year":"2015","journal-title":"Med (United States)"},{"issue":"1","key":"10.1016\/j.nano.2022.102598_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1746-1596-8-29","article-title":"CD44\/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms","volume":"8","author":"Soave","year":"2013","journal-title":"Diagn Pathol"},{"issue":"4","key":"10.1016\/j.nano.2022.102598_bb0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000398801","article-title":"Oral cavity cancer: risk factors, pathology, and management","volume":"89","author":"Ernani","year":"2015","journal-title":"Oncology"},{"issue":"11","key":"10.1016\/j.nano.2022.102598_bb0185","doi-asserted-by":"crossref","first-page":"E1278","DOI":"10.1073\/pnas.1421229112","article-title":"Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome cancer multidrug resistance","volume":"112","author":"Conde","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.nano.2022.102598_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-018-0378-6","article-title":"Nanotechnology: a promising method for oral cancer detection and diagnosis","volume":"16","author":"Chen","year":"2018","journal-title":"J Nanobiotechnol"},{"issue":"11","key":"10.1016\/j.nano.2022.102598_bb0195","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/elan.201600183","article-title":"Multiplex immunosensor arrays for electrochemical detection of cancer biomarker proteins","volume":"28","author":"Munge","year":"2016","journal-title":"Electroanalysis"},{"issue":"35","key":"10.1016\/j.nano.2022.102598_bb0200","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.2174\/13816128113199990375","article-title":"The smart targeting of nanoparticles","volume":"19","author":"Friedman","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nano.2022.102598_bb0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mvr.2017.03.006","article-title":"CD24+ tumor-initiating cells from oral squamous cell carcinoma induce initial angiogenesis in vivo","volume":"112","author":"Zimmerer","year":"2017","journal-title":"Microvasc Res"},{"issue":"1","key":"10.1016\/j.nano.2022.102598_bb0210","first-page":"1133","article-title":"Expression of CD44, CD44V9, ABCG2, CD24, Bmi-1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological factors","volume":"16","author":"Tamatani","year":"2018","journal-title":"Oncol Lett"},{"issue":"4","key":"10.1016\/j.nano.2022.102598_bb0215","doi-asserted-by":"crossref","first-page":"599","DOI":"10.15171\/apb.2018.068","article-title":"Anti-CD24 bio modified PEGylated gold nanoparticles as targeted computed tomography contrast agent","volume":"8","author":"Fazel Ghaziyani","year":"2018","journal-title":"Adv Pharm Bull"},{"issue":"4","key":"10.1016\/j.nano.2022.102598_bb0220","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.3892\/ol.2016.4987","article-title":"Clinicopathological analysis of CD44 and CD24 expression in invasive breast cancer","volume":"12","author":"Jang","year":"2016","journal-title":"Oncol Lett"},{"issue":"6","key":"10.1016\/j.nano.2022.102598_bb0225","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/08941939.2018.1535009","article-title":"Clinicopathological and prognostic value of plasma CD24 level in hepatocellular carcinoma","volume":"33","author":"Maimaitiming","year":"2020","journal-title":"J Investig Surg"},{"issue":"3","key":"10.1016\/j.nano.2022.102598_bb0230","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4103\/1735-3327.284727","article-title":"Evaluation of CD24 and CD44 as cancer stem cell markers in squamous cell carcinoma and epithelial dysplasia of the oral cavity by q- RT-PCR","volume":"17","author":"Mirhashemi","year":"2020","journal-title":"Dent Res J (Isfahan)"},{"issue":"2","key":"10.1016\/j.nano.2022.102598_bb0235","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-0714.2010.00967.x","article-title":"Cancer stem cell immunophenotypes in oral squamous cell carcinoma","volume":"40","author":"Oliveira","year":"2011","journal-title":"J Oral Pathol Med"},{"issue":"7","key":"10.1016\/j.nano.2022.102598_bb0240","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/labinvest.2010.70","article-title":"Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis","volume":"90","author":"Kristiansen","year":"2010","journal-title":"Lab Invest"},{"issue":"10","key":"10.1016\/j.nano.2022.102598_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139112","article-title":"CD24 overexpression is associated with poor prognosis in luminal a and triple-negative breast cancer","volume":"10","author":"Kwon","year":"2015","journal-title":"PLoS One"},{"issue":"1010","key":"10.1016\/j.nano.2022.102598_bb0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1259\/bjr\/59448833","article-title":"Gold nanoparticles as novel agents for cancer therapy","volume":"85","author":"Jain","year":"2012","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.nano.2022.102598_bb0255","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsps.2017.10.012","article-title":"Applications of nanoparticle systems in drug delivery technology","volume":"26","author":"Rizvi","year":"2018","journal-title":"Saudi Pharm J"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963422000843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963422000843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:16:49Z","timestamp":1761549409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963422000843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":51,"alternative-id":["S1549963422000843"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2022.102598","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD24-gold nanocomposite as promising and sensitive biomarker for cancer stem cells in salivary gland tumors","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2022.102598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102598"}}